MP24-07 RELUGOLIX VS LEUPROLIDE EFFECTS ON CASTRATION RESISTANCE-FREE SURVIVAL FROM THE PHASE 3 HERO STUDY IN MEN WITH ADVANCED PROSTATE CANCER

INTRODUCTION AND OBJECTIVE:Androgen deprivation therapy is a foundational therapy for achieving castration levels for men with advanced prostate cancer (aPC). Relugolix, an FDA-approved, oral GnRH ...